Cytolethal distending toxin in Escherichia coli O157:H7: Spectrum of conservation, structure, and endothelial toxicity

Journal of Clinical Microbiology

Volumn 44, Issue 5, 2006, Pages 1844-1846

  Friedrich, Alexander W ^a   Lu, Shan ^a,b   Bielaszewska, Martina ^a   Prager, Rita ^c   Bruns, Phillip ^a   Xu, Jian Guo ^b   Tschäpe, Helmut ^c   Karch, Helge ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b National Institute for Communicable Disease Control and Prevention   (China)

^c ROBERT KOCH INSTITUTE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOLETHAL DISTENDING TOXIN;

ARTICLE; BACTERIAL STRAIN; BACTERIOPHAGE; CYTOTOXICITY; ENDOTHELIUM CELL; ENTEROHEMORRHAGIC ESCHERICHIA COLI; ESCHERICHIA COLI O157; GENE CLUSTER; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STRAIN DIFFERENCE;

ALLELES; BACTERIAL TOXINS; BASE SEQUENCE; CELL LINE; CONSERVED SEQUENCE; DIARRHEA; DNA, BACTERIAL; ENDOTHELIUM, VASCULAR; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI O157; EVOLUTION, MOLECULAR; GENES, BACTERIAL; HEMOLYTIC-UREMIC SYNDROME; HUMANS; MULTIGENE FAMILY; VIRULENCE;

ESCHERICHIA COLI;

EID: 33646598026     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.44.5.1844-1846.2006     Document Type: Article

References (20)

1. Beutin, L., S. Kaulfuss, T. Cheasty, B. Brandenburg, S. Zimmermann, K. Gleier, G. A. Willshaw, and H. R. Smith. 2002. Characteristics and association with disease of two major subclones of Shiga toxin (Verocytotoxin)-producing strains of Escherichia coli (STEC) O157 that are present among isolates from patients in Germany. Diagn. Microbiol. Infect. Dis. 44:337-346.
2. Bielaszewska, M., M. Fell, L. Greune, R. Prager, A. Fruth, H. Tschäpe, M. A. Schmidt, and H. Karch. 2004. Characterization of cytolethal distending toxin genes and expression in Shiga toxin-producing Escherichia coli strains of non-O157 serogroups. Infect. Immun. 72:1812-1816.
3. 2/M arrest, inhibition of proliferation, and death of human endothelial cells. Infect. Immun. 73:552-562.
4. Bielaszewska, M., P. I. Tarr, H. Karch, W. Zhang, and W. Mathys. 2005. Phenotypic and molecular analysis of tellurite resistance among enterohemorrhagic Escherichia coli O157:H7 and sorbitol-fermenting O157:NM clinical isolates. J. Clin. Microbiol. 43:452-454.
5. Cortes-Bratti, X., C. Karlsson, T. Lagergard, M. Thelestam, and T. Frisan. 2001. The Haemophilus ducreyi cytolethal distending toxin induces cell cycle arrest and apoptosis via the DNA damage checkpoint pathways. J. Biol. Chem. 276:5296-5302.
6. Feng, P., K. A. Lampel, H. Karch, and T. S. Whittam. 1998. Genetic and phenotypic changes in the emergence of Escherichia coli O157:H7. J. Infect. Dis. 177:1750-1753.
7. Friedrich, A. W., M. Bielaszewska, W.-L. Zhang, M. Pulz, T. Kuczius, A. Ammon, and H. Karch. 2002. Escherichia coli harboring Shiga toxin 2 gene variants: frequency and association with clinical symptoms. J. Infect. Dis. 185:74-84.
8. -. J. Clin. Microbiol. 42:4697-4701.
9. Hayashi, T., K. Makino, M. Ohnishi, K. Kurokawa, K. Ishii, K. Yokoyama, C. G. Han, E. Ohtsubo, K. Nakayama, T. Murata, M. Tanaka, T. Tobe, T. Iida, H. Takami, T. Honda, C. Sasakawa, N. Ogasawara, T. Yasunaga, S. Kuhara, T. Shiba, M. Hattori, and H. Shinagawa. 2001. Complete genome sequence of enterohemorrhagic Escherichia coli O157:H7 and genomic comparison with a laboratory strain K-12. DNA Res. 8:11-22.
10. - and O157:H7: characterization and evolutionary considerations. Infect. Immun. 71:3634-3638.
11. - from E. coli O157:H7. Appl. Environ. Microbiol. 71:4875-4878.
12. Johnson, W. M., and H. Lior. 1988. A new heat-labile cytolethal distending toxin (CLDT) produced by Escherichia coli isolates from clinical material. Microb. Pathog. 4:103-113.
13. - in Germany-a ten-year study. Int. J. Med. Microbiol. 290:269-278.
14. Mora, A., M. Blanco, J. E. Blanco, M. P. Alonso, G. Dhabi, F. Thomson-Carter, M. A. Usera, R. Bartolomé, G. Prats, and J. Blanco. 2004. Phage types and genotypes of Shiga toxin-producing Escherichia coli O157:H7 isolates from humans and animals in Spain: identification and characterization of two predominating phage types (PT2 and PT8). J. Clin. Microbiol. 42:4007-4015.
15. Perna, N. T., G. Plunket III, V. Burland, B. Mau, J. D. Glasner, D. J. Rose, G. F. Mayhew, P. S. Evans, J. Gregor, H. A. Kirkpatrick, G. Posfai, J. Hackett, S. Klink, A. Boutin, Y. Shao, L. Miller, E. J. Grotbeck, N. W. Davis, A. Lim, E. T. Dimalanta, K. D. Potamousis, J. Apodaca, T. S. Anantharaman, J. Lin, G. Yen, D. C. Schwartz, R. A. Welch, and F. R. Blattner. 2001. Genome sequence of enterohaemorrhagic Escherichia coli O157:H7. Nature 409:529-533.
16. Preston, M. A., W. Johnson, R. Khakhria, and A. Borczyk. 2000. Epidemiologic subtyping of Escherichia coli serogroup O157 strains isolated in Ontario by phage typing and pulsed-field gel electrophoresis. J. Clin. Microbiol. 38:2366-2368.
17. Sonntag, A.-K., R. Prager, M. Bielaszewska, W. Zhang, A. Fruth, H. Tschäpe, and H. Karch. 2004. Phenotypic and genotypic analyses of enterohemorrhagic Escherichia coli O145 strains from patients in Germany. J. Clin. Microbiol. 42:954-962.
18. Tarr, P. I., C. A. Gordon, and W. L. Chandler. 2005. Shiga toxin-producing Escherichia coli and the haemolytic uraemic syndrome. Lancet 365:1073-1086.
19. Thelestam, M., and T. Frisan. 2004. Cytolethal distending toxins. Rev. Physiol. Biochem. Pharmacol. 152:111-133.
20. Willshaw, G. A., H. R. Smith, T. Cheasty, P. G. Wall, and B. Rowe. 1997. Vero cytotoxin-producing Escherichia coli O157 outbreaks in England and Wales, 1995: phenotypic methods and genotypic subtyping. Emerg. Infect. Dis. 3:561-565.